Yuki Akazawa

1PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 12, 2022
Non-small cell lung cancer with tumor proportion score > 90% could increase the risk of severe immune-related adverse events in first-line treatments with immune checkpoint inhibitors: A retrospective single-center study.

Yuki Akazawa, Aki Yoshikawa, Masaki Kanazu

Pageof 1

Frequent Collaborators

1 joint publications

Masaki Kanazu